Actavis Pharma Metformin Hydrochloride Tablet Recall [US]

Actavis Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US FlagUS/Silver Spring: Teva Pharmaceuticals USA, Inc., a Parsippany, New Jersey establishment and subsidiary of Teva Pharmaceutical Industries Ltd. of Petah Tikva, Israel, recalls certain batch/lots of Actavis Pharma, Inc. branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/q9Pu30qOed1

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-initiates-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Continue reading

%d bloggers like this: